Compare Alcon AG (ALC) vs Heron Therapeutics Inc (HRTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Alcon AG vs Heron Therapeutics Inc — how do they compare? Alcon AG trades at $72.57 (market cap $36.44B), while Heron Therapeutics Inc trades at $0.32 (market cap $61.47M). The key difference: Alcon AG is far larger — about 592.8× Heron Therapeutics Inc's market cap, and Alcon AG pays a 0.48% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ALC | HRTX | |
|---|---|---|
Market Cap | $36.44B | $61.47M |
Sector | Health | Health |
52-Week High | $90.12 | $1.49 |
52-Week Low | $62.02 | $0.32 |
Enterprise Value | $40.28B | $168.21M |
Dividend Yield | 0.48% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Alcon AG
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →
